IBM Reports Tonight — Analysts Have Already Moved, Bears Have Not

Short sellers have not followed the analyst downgrades with conviction. Short interest climbed about 13% over the past month to roughly 3.8% of free float — elevated for IBM by recent standards but not extreme. Critically, the borrow market is wide open: availability runs above 1,400% of shares borrowed, meaning there is far more lending supply than active demand for shorts. Cost to borrow ticked up about 20% on the week but remains negligible at 0.47% annually. The ORTEX short score holds near 38 — in the lower half of the universe — consistent with the picture from prior notes: shorts are adding incrementally, not pressing a concentrated bet. Options tell a slightly more cautious story. The put/call ratio is running at 0.78, modestly above its 20-day average of 0.72 and about 1.2 standard deviations above that mean — not an alarm, but a tilt toward defensive hedging ahead of the print.

IBM's earnings history adds a relevant data point. The April 22 Q1 print produced a day-one decline of 9.6% followed by a further drop to -11.2% over five trading days — the sharpest post-earnings reaction in recent history. The stock enters tonight's release already down 15% in a month and 3% on the week, meaning a significant portion of pre-print anxiety is already reflected in the price. Peers offered a mixed week: ACN gained nearly 5% on the week while CTSH added 1.4% and DXC rose 1.6%. IBM's underperformance against the IT services group through the week suggests the stock has absorbed more sector-specific or IBM-specific pessimism rather than riding a rising tide.

Institutional ownership provides a stable backdrop. BlackRock holds 8.3% of shares and added nearly a million shares in the most recent reported period ending June 30. State Street and Geode both added incrementally. There is no sign of large institutional exits, though the data lags the recent drawdown. Insider activity is modest — an SVP sold roughly $1.2 million in early July, and the 90-day net is a marginal positive driven by director purchases in February. Nothing in the insider register signals unusual conviction in either direction heading into the print.

The earnings release tonight is therefore less about whether IBM can demonstrate consulting recovery and more about whether management's AI and software revenue commentary can shift the narrative that drove six weeks of target reductions.